Table of Contents

1. Executive Summary

2. North America Diabetes Population (2011 – 2022): An Analysis
2.1 United States
2.1.1 Overall Diabetes Population
2.1.1.1 Type 1 Diabetes
2.1.1.2 Type 2 Diabetes
2.1.1.3 Newly Diagnosed Type 1 Diabetes
2.2 Canada
2.2.1 Overall Diabetes Population
2.2.1.1 Type 1 Diabetes
2.2.1.2 Type 2 Diabetes
2.2.1.3 Newly Diagnosed Type 1 Diabetes
2.3 Mexico
2.3.1 Overall Diabetes Population
2.3.1.1 Type 1 Diabetes
2.3.1.2 Type 2 Diabetes
2.3.1.3 Newly Diagnosed Type 1 Diabetes

3. North America Insulin Pump Market Prospect & Growth (2011 – 2022)
3.1 Insulin Pump Users
3.2 Insulin Pump Market

4. North America Insulin Pump Market Share – By Countries (2011 – 2022)
4.1 Insulin Pump Users Share
4.2 Insulin Pump Market Share

5. North America Insulin Pump Market Analysis – By Countries (2011– 2022)
5.1 United States
5.1.1 Insulin Pump Users
5.1.2 Insulin Pump Market
5.1.3 United States Insulin Pump Preferred Brand – By Product
5.1.3.1 Pediatric
5.1.3.2 Adult
5.2 Canada
5.2.1 Insulin Pump Users
5.2.2 Insulin Pump Market
5.3 Mexico
5.3.1 Insulin Pump Users
5.3.2 Insulin Pump Market

6. Key Drivers and Inhibitors of the North America Insulin Pump Market
6.1 Market Drivers
6.2 Inhibitors

7. North America Insulin Pump Market: Reimbursement & Regulation System
7.1 United States
7.1.1 Reimbursement System
7.1.2 Regulation System
7.2 Canada
7.2.1 Reimbursement System
7.2.2 Regulation System
7.3 Mexico
7.3.1 Regulation System

8. North America Insulin Pump Market – Major Deal Types
8.1 Insulin Pump Market – Collaboration Deals
8.2 Insulin Pump Market – Licensing Agreement
8.3 Insulin Pump Market – Exclusive Agreement
8.4 Insulin Pump Market – Partnerships Deals

9. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2016
9.2 Year 2015
9.3 Year 2014
9.4 Year 2013
9.5 Year 2012

10. Key Companies Analysis
10.1 Medtronic
10.1.1 Business Overview
10.1.2 Insulin Pump – Product Details
10.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
10.1.4 Insulin Pump – Latest Development & Trends
10.2 Tandem Diabetes Care
10.2.1 Business Overview
10.2.2 Insulin Pump – Product Details
10.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
10.2.4 Insulin Pump – Latest Development & Trends
10.3 Insulet Corporation
10.3.1 Business Overview
10.3.2 Insulin Pump – Product Details
10.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
10.3.4 Insulin Pump – Latest Development & Trends
10.4 Animas Corporation (Johnson & Johnson)
10.4.1 Business Overview
10.4.2 Insulin Pump – Product Details
10.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
10.4.4 Insulin Pump – Latest Development & Trends
10.5 Roche
10.5.1 Business Overview
10.5.2 Insulin Pump – Product Details
10.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
10.5.4 Insulin Pump – Latest Development & Trends
10.6 Microport
10.6.1 Business Overview
10.6.2 Insulin Pump – Product Details
10.6.3 Microport – Global Diabetes Sales Analysis & Forecast (2013 – 2022)
10.6.4 Insulin Pump – Latest Development & Trends
10.7 Sooil Development
10.7.1 Business Overview
10.7.2 Insulin Pump – Product Details
10.7.3 Insulin Pump – Latest Development & Trends

List of Tables

Table 4–1: North America – Insulin Pump Users Share (Percent), 2011 – 2016
Table 4–2: North America – Forecast for Insulin Pump Users Share (Percent), 2017 – 2022
Table 4–3: North America – Insulin Pump Market Share (Percent), 2011 – 2016
Table 4–4: North America – Forecast for Insulin Pump Market Share (Percent), 2017 – 2022
Table 6–1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 8–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 8–2: Licensing Agreement in Insulin Pump Market, 2015 – 2016
Table 8–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2017
Table 8–4: Partnerships Deals in Insulin Pump Market, 2010 – 2017

"
List of Figures

Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 2–9: Canada – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–10: Canada – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–11: Canada – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–12: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–13: Canada – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–14: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–15: Canada – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–16: Canada – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 2–17: Mexico – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–18: Mexico – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–19: Mexico – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–20: Mexico – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–21: Mexico – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–22: Mexico – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–23: Mexico – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–24: Mexico – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3–1: North America – Insulin Pump Users (Number), 2011 – 2016
Figure 3–2: North America – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–3: North America – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3–4: North America – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 5–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–3: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–4: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–5: United States – Pediatric Insulin Pump Preference by Product(Percent),2016
Figure 5–6: United States – Adult Insulin Pump Preference by Product(Percent),2016
Figure 5–7: Canada – Insulin Pump Users (Number), 2011 – 2016
Figure 5–8: Canada – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–9: Canada – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–10: Canada – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 5–11: Mexico – Insulin Pump Users (Number), 2011 – 2016
Figure 5–12: Mexico – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 5–13: Mexico – Insulin Pump Market (Million US$), 2011 – 2016
Figure 5–14: Mexico – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 10–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 10–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 10–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 10–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 10–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 10–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 10–11: Microport – Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 10–12: Microport – Forecast for Diabetes Sales Analysis (Million US$),2017 – 2022
 
"